Cancer Treatment News and Research

RSS

Cancer patients favor early financial risk assessments

Patients with cancer want their care team to assess them early in treatment about their concerns related to costs of care, reports a Northwestern Medicine study.

17 Sep 2024

Study reveals higher breast cancer mortality risk for black women across all tumor types

Breast cancer is the most diagnosed cancer among U.S. women and the second leading cause of cancer death.

17 Sep 2024

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.

17 Sep 2024

Ohio State's novel DHODH inhibitor enters first human trials

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

17 Sep 2024

ESMO Congress 2024 to unveil future-focused cancer treatments

The ESMO Congress 2024 will hold a press conference to introduce and discuss the "Eyes to the Future" Presidential Symposium 3, that will be presenting prominent approaches that have the potential to become increasingly effective and influential components of cancer treatment in the (near) future.

16 Sep 2024

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to recognize and attack cancer cells more effectively.

16 Sep 2024

Key enzyme identified as potential target for cancer treatment

During every moment of any living organism's life, enzymes are at work. These crucial proteins support life through most biological processes, including metabolism, movement, respiration, and digestion.

14 Sep 2024

PPARs and PROTACs: A new strategy in cancer therapeutics

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects.

13 Sep 2024

Salt can boost antitumor responses of T cells

Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving cancer therapies.

13 Sep 2024

Novel drug delivery system aims to prevent hearing loss from cisplatin chemotherapy

The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect that can diminish quality of life following treatment.

13 Sep 2024

$Hypofractionation proven safer and more convenient for breast cancer treatment$

Hypofractionation proven safer and more convenient for breast cancer treatment

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a conventional schedule, finds a study published by The BMJ today.

13 Sep 2024

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients.

12 Sep 2024

Nucleophagy identified as key DNA repair mechanism in cancer treatments

A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.

12 Sep 2024

Five key factors identified for predicting immunotherapy response in cancer patients

Immunotherapy has transformed cancer treatment in recent years by enabling the immune system to attack tumor cells.

12 Sep 2024

NCCN expands cancer guidelines library with Spanish translations and more languages

The National Comprehensive Cancer Network;an alliance of leading cancer centers - and the NCCN Foundation proudly announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.

12 Sep 2024

Duffy-null phenotype may lead to unfair exclusion from cancer drug trials

Many clinical trials of new cancer drugs may be inappropriately excluding some people with "Duffy-null phenotype," a trait found predominantly in people of African or Middle Eastern descent, researchers at Dana-Farber Cancer Institute and Queen Mary University of London report in a new study.

12 Sep 2024

Cognitive behavioral therapy boosts quality of life for young cancer patients

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.

10 Sep 2024

Bioactive glasses with gallium show promise for bone cancer treatment

Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer.

10 Sep 2024

Research confirms safety of breastfeeding for breast cancer survivors with BRCA mutations

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer), do not face an increased risk of recurrence or developing new breast cancers.

9 Sep 2024

The impact of microgravity on cancer development and treatment

The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS). The project, one of only five chosen through a competitive solicitation by the ISS National Lab in partnership with NASA, aims to explore the effects of microgravity on cancer development and treatment.

6 Sep 2024

Cancer Treatment News and Research

Cancer patients favor early financial risk assessments

Study reveals higher breast cancer mortality risk for black women across all tumor types

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

Ohio State's novel DHODH inhibitor enters first human trials

ESMO Congress 2024 to unveil future-focused cancer treatments

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Key enzyme identified as potential target for cancer treatment

PPARs and PROTACs: A new strategy in cancer therapeutics

Salt can boost antitumor responses of T cells

Novel drug delivery system aims to prevent hearing loss from cisplatin chemotherapy

Hypofractionation proven safer and more convenient for breast cancer treatment

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

Nucleophagy identified as key DNA repair mechanism in cancer treatments

Five key factors identified for predicting immunotherapy response in cancer patients

NCCN expands cancer guidelines library with Spanish translations and more languages

Duffy-null phenotype may lead to unfair exclusion from cancer drug trials

Cognitive behavioral therapy boosts quality of life for young cancer patients

Bioactive glasses with gallium show promise for bone cancer treatment

Research confirms safety of breastfeeding for breast cancer survivors with BRCA mutations

The impact of microgravity on cancer development and treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News